MedTrace Logo

A Study Evaluating Good Idea on Glucose Homeostasis in a Healthy Population

NCT03152682 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-11-22

No results posted yet for this study

Summary

A crossover design to evaluate the safety and efficacy of GoodIdea TM (trademark) on glucose homeostasis in a healthy population. Eligible participants will be given either the GoodIdea drink or placebo and a standardized meal and will consume both in approximately 15 minutes. Blood will be drawn at several time points over a 3 hour period to determine the study objectives. After a 7-day washout, the participants will come back to the clinic and and complete the visit consuming the opposite product given at the previous visit. The primary objective is to see the difference of the two-hour iAUC for intravenous blood glucose between the active product (GoodIdea) and the placebo following a standardized meal.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

GoodIdea

Active product. Amount: 355mL. Consumed at a clinic visit over 14 minutes.

OTHER

Placebo

Non-active placebo product. Amount: 355mL. Consumed at a clinic visit over 14 minutes.

Sponsors & Collaborators

  • KGK Science Inc.

    collaborator INDUSTRY

  • DoubleGood AB

    lead INDUSTRY

Principal Investigators

  • Tetyana Pelipyagina, MD · KGK Science Inc.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-22
Primary Completion
2017-08-15
Completion
2017-08-15

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03152682 on ClinicalTrials.gov